Atlas Trials

Oral Miltefosine Plus Topical Paromomycin In American Cutaneous Leishmaniasis

Clinical trial NCT03829917 · COMPLETED

Trial details

NCT number
NCT03829917
Sponsor
Fundacion Nacional de Dermatologia
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Cutaneous Leishmaniasis, American
Start date
2019-02-01
Primary completion
2020-12-01
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.